STOCKTON, CA, March 04, 2026 /24-7PressRelease/ -- On Tuesday, March 17, at 8:00 p.m. Eastern, four companies with distinct approaches to health and sustainability will take the virtual stage for the Superpowers for Good Live Pitch, a televised, two-hour event that gives mission-driven businesses a national platform to share their investment opportunity with the public.

The presenting companies—My Diabetes Health, rHEALTH, GigaWatt, and BRG Therapeutics—will pitch live on television, with the broadcast designed to include the audience in real time. Television viewers will be invited to submit questions for the founders; selected questions will be asked during the broadcast. Viewers will also vote live to select the SuperCrowd Award winner, while the expert judging panel will choose a separate judges' selection.

Immediately following the broadcast, the production will host a private investor session via Zoom, open to anyone interested in investing in one or more of the companies. Registration is free at: https://thesupercrowd.com/26q1pitch.

The event is produced by The Super Crowd, Inc., a public benefit corporation focused on building a bigger tent for impact crowdfunding—helping investors discover high-impact opportunities and helping entrepreneurs reach the capital and community they need to grow.

"Taken together, these four companies show how broad the 'impact' category really is," said Léa Bouhelier-Gautreau, a Senior Investment Associate in Impact Investing at KingsCrowd. "Impact can be preventive health and patient education. It can be better diagnostics that shorten the time between suspicion and certainty. It can be energy infrastructure that helps households and businesses navigate electrification. And it can be the earliest stages of therapeutics, where the upside can be enormous, but the path is demanding. This event lets the public see—and question—those differences in a live setting."

A live broadcast designed for real investor curiosity
Superpowers for Good is built around the idea that entrepreneurs can pair commercial ambition with measurable public benefit—and that investors, when given direct access, will ask sharper questions than any marketing copy can anticipate.

Sherwood Neiss, a General Partner at Crowdfund Capital Advisors and a longtime voice in the investing and crowdfunding ecosystem, said the format is intentionally structured to go beyond polished pitches.

"A pitch should be persuasive—but it should also be testable," Neiss said. "When you give viewers the chance to ask questions and hear answers live, you get closer to what investing actually feels like: a decision made with imperfect information, strengthened by clarity. The companies that do well in this setting are usually the ones that can explain their evidence, their plan, and their risks without spinning."

Paul Lovejoy, a Principal Investment Advisor at Stakeholder Enterprise who works with investors navigating crowd investing opportunities, added that audience participation changes the energy of the broadcast—especially when the questions come from people actively considering an investment.

"Founders can sense the difference between a passive audience and an audience that's doing diligence," Lovejoy said. "When questions come in from viewers and get asked on-air, it tends to elevate the conversation. It also creates fairness: the same core questions—traction, validation, economics, and execution—get surfaced in real time for everyone watching."

The four companies pitching March 17
My Diabetes Health: Diabetes management through education—delivered via telehealth
My Diabetes Health is presenting a model centered on insurance-covered telehealth diabetes education, designed to help patients improve health outcomes through access to diabetes self-management training and support. The company says it has served 8,600 patients and that patients using its program have achieved an average 1.6-point A1C improvement, a widely used measure of blood sugar control over time.

The company's pitch is expected to focus on how education—when delivered consistently, in accessible formats—can function as a scalable intervention for a chronic condition that affects tens of millions of Americans. The company also emphasizes accessibility, including multi-language support and a care model designed to remove barriers tied to geography and scheduling.

"What I'll be listening for is how the company translates outcomes into a repeatable operating system," Bouhelier-Gautreau said. "If the results are strong, investors will want to understand what drives them: patient engagement, clinician workflow, payer relationships, and retention. The impact case is clear. The investment case comes down to the mechanics of scaling without losing effectiveness."

rHEALTH: Space-validated diagnostics aimed at point-of-care use
rHEALTH describes itself as developing a space-validated blood diagnostics platform intended for consumer and point-of-care use—designed to return results and interpretation in minutes rather than days. The company points to work connected to NASA and NIH as part of its development story, along with prior funding from multiple sources including government and industry partners.

The pitch is expected to focus on speed, accessibility, and the practical value of diagnostics that can be deployed where people receive care—or where they lack access to traditional labs.

"Diagnostics is a field where credibility is earned through specifics," Neiss said. "Investors will want to hear the company explain exactly what's validated today, what the regulatory plan is, and who the first clear customer is. The promise here is compelling. The work is in defining the shortest, most defensible path from capability to adoption."

Lovejoy added that the story will resonate most if the company can translate technical sophistication into simple, investable clarity. "The question isn't just 'Is it impressive?' It's 'How does it fit into the real world?' What settings will use it first? What does reimbursement look like? What constraints does it solve? Those are the kinds of questions viewers tend to ask—and now they'll get to ask them directly."

GigaWatt: An established energy business aiming to scale a fragmented market
GigaWatt positions itself as an established business working to help scale the future of distributed energy. The company says it has been in business for 19 years, has generated more than $54 million in revenue since 2019, and has earned a 4.7 collective rating across 1,300 verified Google reviews. It also describes itself as 100% bootstrapped, framing its growth as operationally driven rather than venture-funded.

The company's pitch is expected to connect its operating track record to a broader market tailwind: the accelerating shift toward electrification, solar, storage, and smarter energy management—where consumers often need not only equipment, but trustworthy implementation, integration, and support.

"In energy, a lot of businesses talk like platforms," Bouhelier-Gautreau said. "What's interesting here is the claim of long-term operations and customer feedback at scale. Investors will want to understand where the defensibility sits—brand, distribution, execution capability, technology, or some combination—and what changes as the company pursues a larger footprint."

Neiss noted that experience can be a differentiator in a market crowded with new entrants. "Operating history can be its own form of validation," he said. "But scaling is its own discipline. The best pitches will show not only what's been built, but what's been learned—and how the next stage will be executed."

BRG Therapeutics: Dual-action therapeutics targeting cancer and viral diseases
BRG Therapeutics describes its mission as developing novel anticancer and antiviral therapeutics, positioning its approach as dual-action across two high-need therapeutic areas. The company cites the scale of the markets it aims to address and is expected to outline a development plan focused on research milestones and preclinical work.

Lovejoy emphasized that early-stage therapeutics demands a different lens from consumer-facing ventures. "This category can't be evaluated with the same playbook as a service business," he said. "Investors will want a clear, disciplined roadmap: what stage the science is at, what the next milestones are, what the validation plan is, and what partnerships would materially de-risk the path. A strong pitch doesn't oversell certainty—it makes the plan understandable."

Bouhelier-Gautreau added that transparency matters as much as ambition. "The most credible early-stage biotech pitches are the ones that can say, plainly, what's known, what's hypothesized, and what remains to be proven. That's when investors can make a real decision."

Viewers will ask the questions—and pick an award winner
The March 17 broadcast is designed to make the audience part of the event rather than a passive viewership experience. During the live show, television viewers will be invited to submit questions to the production team for the founders. Selected questions will be asked on-air, giving the public a chance to hear founders respond in real time.

In addition, viewers will vote live for the SuperCrowd Award winner during the broadcast. Separately, the three-judge panel will confer and select its own judges' choice.

"Crowd investing is rooted in participation," Thorpe said. "So we've built this event to reflect that—from the live questions, to the viewer vote, to the investor session afterward. It's a live show, but it's also a live conversation."

How to watch—and how to join the investor session
The Superpowers for Good Live Pitch will air live on Roku and Amazon Fire TV via the e360tv Network, with additional distribution via social channels. Immediately following the televised livestream, the production will host a private investor session via Zoom where interested viewers can engage founders with deeper questions.

Registration for the investor session is free at: https://thesupercrowd.com/26q1pitch.

About Superpowers for Good Live Pitch
Superpowers for Good Live Pitch is a quarterly, televised event produced by The Super Crowd, Inc. It highlights high-impact businesses raising capital from the crowd and brings together entrepreneurs, investors, and expert judges for a live pitch, live audience Q&A, and an open-to-the-public investor session.

The Superpowers for Good Live Pitch is produced by The Super Crowd, Inc., a public benefit corporation dedicated to advancing impact crowdfunding and empowering diverse founders. The event brings together social entrepreneurs, impact investors, and ecosystem leaders to build a more inclusive and sustainable economy. Learn more at https://TheSuperCrowd.com.

# # #